• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease-Perception and Reality.

作者信息

Kuriakose Kuzhiyanjal Anish J, Subramanian Sreedhar, Limdi Jimmy K

机构信息

Division of Gastroenterology-Section of IBD, Northern Care Alliance NHS Foundation Trust, Manchester, UK.

Department of Gastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

出版信息

Dig Dis Sci. 2025 Mar;70(3):1246-1247. doi: 10.1007/s10620-025-08855-w. Epub 2025 Jan 22.

DOI:10.1007/s10620-025-08855-w
PMID:39843791
Abstract
摘要

相似文献

1
Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease-Perception and Reality.炎症性肠病患者生物治疗起始延迟——认知与现实
Dig Dis Sci. 2025 Mar;70(3):1246-1247. doi: 10.1007/s10620-025-08855-w. Epub 2025 Jan 22.
2
Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.术后预防性生物治疗在克罗恩病患者中延迟启动较为常见。
Dig Dis Sci. 2019 Jan;64(1):196-203. doi: 10.1007/s10620-018-5159-4. Epub 2018 Jun 7.
3
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.与炎症性肠病患者开始生物治疗的延迟相关的因素。
Dig Dis Sci. 2024 Aug;69(8):2796-2803. doi: 10.1007/s10620-024-08514-6. Epub 2024 Jul 4.
4
Delays Related to Prior Authorization in Inflammatory Bowel Disease.炎症性肠病相关的预先授权延误。
Pediatrics. 2022 Mar 1;149(3). doi: 10.1542/peds.2021-052501.
5
Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study.炎症性肠病患者起始生物治疗后体重变化的评估：一项前瞻性队列研究。
Dig Dis Sci. 2020 Dec;65(12):3672-3678. doi: 10.1007/s10620-020-06442-9. Epub 2020 Jul 2.
6
Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study.炎症性肠病患者使用生物制剂治疗后疲劳的纵向轨迹：一项前瞻性队列研究。
J Crohns Colitis. 2020 Mar 13;14(3):309-315. doi: 10.1093/ecco-jcc/jjz148.
7
The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study.联合生物或小分子治疗在炎症性肠病中的应用：一项回顾性队列研究。
J Dig Dis. 2020 May;21(5):264-271. doi: 10.1111/1751-2980.12867. Epub 2020 Jun 11.
8
Exposure to biologic therapy and associated maternal and neonatal outcomes in pregnancies complicated by inflammatory bowel disease.炎症性肠病孕妇中生物治疗的暴露及其母婴结局。
Am J Obstet Gynecol MFM. 2022 Jan;4(1):100518. doi: 10.1016/j.ajogmf.2021.100518. Epub 2021 Oct 22.
9
Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease.长期使用阿片类药物与炎症性肠病患者早期生物制剂停药有关。
Aliment Pharmacol Ther. 2021 Mar;53(6):704-711. doi: 10.1111/apt.16269. Epub 2021 Jan 26.
10
Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission.抑郁症状会增加缓解期小儿炎症性肠病患者开始或转为生物治疗的风险。
BMC Gastroenterol. 2023 Oct 13;23(1):355. doi: 10.1186/s12876-023-02993-z.

引用本文的文献

1
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease.生物疗法使用的延迟是一个全球普遍存在的现实情况，并且可能给炎症性肠病患者带来负面后果。
Dig Dis Sci. 2025 Mar;70(3):1248-1249. doi: 10.1007/s10620-025-08920-4. Epub 2025 Feb 28.

本文引用的文献

1
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.与炎症性肠病患者开始生物治疗的延迟相关的因素。
Dig Dis Sci. 2024 Aug;69(8):2796-2803. doi: 10.1007/s10620-024-08514-6. Epub 2024 Jul 4.
2
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.一种生物标志物分层比较新诊断克罗恩病患者自上而下与加速阶梯治疗策略的效果（PROFILE）：一项多中心、开放标签随机对照试验。
Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22.
3
Establishing key performance indicators for inflammatory bowel disease in the UK.
确立英国炎症性肠病的关键绩效指标。
Frontline Gastroenterol. 2023 May 25;14(5):407-414. doi: 10.1136/flgastro-2023-102409. eCollection 2023.
4
Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.诱导治疗早期缓解可预测炎症性肠病的长期缓解：一项系统评价和荟萃分析
Am J Gastroenterol. 2023 Nov 1;118(11):2084-2087. doi: 10.14309/ajg.0000000000002328. Epub 2023 May 19.
5
Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn's disease.系统评价和荟萃分析：生物制剂早期治疗成人和儿童克罗恩病的疗效和安全性。
Aliment Pharmacol Ther. 2020 May;51(9):831-842. doi: 10.1111/apt.15685. Epub 2020 Mar 23.